MIMS Education

Beyond symptom control: Rethinking the approach to managing allergic rhinitis (AR)

Beyond symptom control: Rethinking the approach to managing allergic rhinitis (AR)

Allergy And Immunology
A badge with ribbon in color black 1 point | An analog clock in color black 2 hours | A black calendar with white triangle in center that has a black exclamation point in the middle 14 Aug 2021 

Overview

NEW!

Most patients with AR are not treated according to guidelines and adherence to treatment is poor. This has prompted the development of next-generation Allergic Rhinitis and its Impact on Asthma (ARIA) – a refined ARIA initiative that emphasises integrated patient-centred care. 

This module aims to provide doctors with an overview of the management of AR and the positioning of a single-dose azelastine–fluticasone propionate combination (MPAze-Flu) according to next-generation ARIA.

Reviewer: Dr Yap Yoke Yeow
Otorhinolaryngologist
KPJ Johor Specialist Centre

NOTE :

Please read thoroughly & understand the module before attempting the assessment questions.

Terms & Conditions: 

■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point. 
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points. 


The modules/articles are best viewed with:

Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards compliant browser
may be required to view the modules.